Patents Assigned to Elysium Health, Inc.
  • Patent number: 12128060
    Abstract: Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: October 29, 2024
    Assignee: Elysium Health, Inc.
    Inventors: Ryan Dellinger, Santiago Roel Santos, Eric A. Marcotulli, Daniel A. Alminana, Mark Morris, Leonard Pershing Guarente
  • Patent number: 12109206
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
    Type: Grant
    Filed: July 25, 2022
    Date of Patent: October 8, 2024
    Assignee: Elysium Health, Inc.
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen
  • Patent number: 12043616
    Abstract: Provided herein are crystalline forms of nicotinamide riboside chloride and methods of making the same. Also provided are compositions comprising the crystalline form of nicotinamide riboside chloride, and therapeutic methods employing the crystalline form of nicotinamide riboside chloride.
    Type: Grant
    Filed: August 12, 2022
    Date of Patent: July 23, 2024
    Assignee: Elysium Health, Inc.
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
  • Patent number: 11998561
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating neurodegenerative disorders, and methods of treating neurodegenerative disorders using these compositions and their equivalents are described. The neurodegenerative disorders that can be treated using these compositions or methods can include Parkinson's disease, Huntington's disease, Alzheimer's disease, and the like. In an embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene can be prepared as oral formulations. In some embodiments, a dietary supplement comprises nicotinamide riboside and/or pterostilbene or equivalents.
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: June 4, 2024
    Assignee: Elysium Health, Inc.
    Inventors: Eric Alexander Marcotulli, Daniel Antonio Alminana
  • Patent number: 11730751
    Abstract: Provided herein are methods and compositions related to treating motor neuron diseases, such as ALS, in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: August 22, 2023
    Assignees: UNIVERSITAT DE VALÈNCIA-ESTUDI GENERAL, FUNDACIÓN UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR, Elysium Health, Inc.
    Inventors: José Maria Estrela Ariguel, José Enrique De La Rubia Orti, Ryan Dellinger
  • Patent number: 11629163
    Abstract: Provided herein are efficient and scalable methods for the synthesis of nicotinamide riboside from riboside triacetate. Also provided are compositions comprising nicotinamide riboside, and therapeutic methods employing nicotinamide riboside.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: April 18, 2023
    Assignee: Elysium Health, Inc.
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris, Rajesh Thamatam
  • Patent number: 11426398
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: August 30, 2022
    Assignee: Elysium Health, Inc.
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen
  • Patent number: 11414407
    Abstract: Provided herein are crystalline forms of nicotinamide riboside chloride and methods of making the same. Also provided are compositions comprising the crystalline form of nicotinamide riboside chloride, and therapeutic methods employing the crystalline form of nicotinamide riboside chloride.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: August 16, 2022
    Assignee: Elysium Health, Inc.
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
  • Patent number: 11389468
    Abstract: Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: July 19, 2022
    Assignee: Elysium Health, Inc.
    Inventors: Ryan Dellinger, Santiago Roel Santos, Eric Marcotulli, Daniel A. Alminana, Mark Morris, Leonard Pershing Guarente
  • Patent number: 11260069
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating neurodegenerative disorders, and methods of treating neurodegenerative disorders using these compositions and their equivalents are described. The neurodegenerative disorders that can be treated using these compositions or methods can include parkinson's disease, huntington's disease, alzheimer's disease, and the like. In an embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene can be prepared as oral formulations. In some embodiments, a dietary supplement comprises nicotinamide riboside and/or pterostilbene or equivalents.
    Type: Grant
    Filed: August 22, 2017
    Date of Patent: March 1, 2022
    Assignee: Elysium Health, Inc.
    Inventors: Eric Alexander Marcotulli, Daniel Antonio Alminana
  • Patent number: 11129843
    Abstract: Provided herein are methods and compositions related to treating and/or preventing kidney related diseases and disorders, treating and/or preventing acute kidney injury, and for improving kidney health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: September 28, 2021
    Assignee: Elysium Health, Inc.
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Leonard Pershing Guarente, Ryan Dellinger, Mark Morris